ReviewGeroScience2026
A systematic review of the association between phase angle and cognitive function among older adults.
Review in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ageing is characterised by the coupled decline of somatic and neural integrity. While the global burden of dementia continues to rise, scalable markers that capture this systemic vulnerability to identify individuals at risk remain scarce. Phase angle (PhA), a bioelectrical impedance analysis-derived metric reflecting cellular membrane integrity and body cell mass, has been linked to frailty and mortality; however, its potential as a sentinel for cognitive decline has not been systematically synthesised. We searched five databases up to October 30, 2025, and identified 12 observational studies comprising 7588 adults aged 65 years or older. Methodological quality was independently assessed using the JBI Critical Appraisal Checklist for Analytical Cross-Sectional Studies and the JBI Critical Appraisal Checklist for Cohort Studies by two reviewers. Any inconsistencies were addressed by a third reviewer. Our synthesis reveals a consistent positive association: higher whole-body PhA correlates with better global cognition and lower odds of cognitive impairment, with effect sizes of approximately 0.6 Mini-Mental State Examination points per one-degree increase in PhA. Crucially, segmental analyses identified leg PhA-but not arm or trunk PhA-as a robust correlate of cognitive function, suggesting a specific link via the muscle-brain axis. These findings position PhA, particularly of the lower extremities, as a scalable, non-invasive biomarker integrating somatic and brain ageing. Incorporating PhA into geriatric assessment could refine early risk stratification in primary care, a strategy that now warrants validation in large-scale longitudinal cohorts.
Indexed as
Identifiers
41986555What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.